107 related articles for article (PubMed ID: 12413881)
1. Human CD34+ hematopoietic progenitor cells hyperacetylate core histones in response to sodium butyrate, but not trichostatin A.
Travers H; Spotswood HT; Moss PA; Turner BM
Exp Cell Res; 2002 Nov; 280(2):149-58. PubMed ID: 12413881
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of histone deacetylases by Trichostatin A leads to a HoxB4-independent increase of hematopoietic progenitor/stem cell frequencies as a result of selective survival.
Obier N; Uhlemann CF; Müller AM
Cytotherapy; 2010 Nov; 12(7):899-908. PubMed ID: 20210674
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors.
Bradbury CA; Khanim FL; Hayden R; Bunce CM; White DA; Drayson MT; Craddock C; Turner BM
Leukemia; 2005 Oct; 19(10):1751-9. PubMed ID: 16121216
[TBL] [Abstract][Full Text] [Related]
4. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils.
Ishihara K; Hong J; Zee O; Ohuchi K
Br J Pharmacol; 2004 Jul; 142(6):1020-30. PubMed ID: 15210580
[TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of histone acetylation turnover and Trichostatin A induced hyper- and hypoacetylation in alfalfa.
Waterborg JH; Kapros T
Biochem Cell Biol; 2002; 80(3):279-93. PubMed ID: 12123281
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide screening for target regions of histone deacetylases in cardiomyocytes.
Kaneda R; Ueno S; Yamashita Y; Choi YL; Koinuma K; Takada S; Wada T; Shimada K; Mano H
Circ Res; 2005 Aug; 97(3):210-8. PubMed ID: 16002748
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.
Camarero N; Nadal A; Barrero MJ; Haro D; Marrero PF
Nucleic Acids Res; 2003 Mar; 31(6):1693-703. PubMed ID: 12626711
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells.
Karasawa Y; Okisaka S
Jpn J Ophthalmol; 2004; 48(6):542-51. PubMed ID: 15592778
[TBL] [Abstract][Full Text] [Related]
9. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
Chen YX; Fang JY; Lu J; Qiu DK
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516
[TBL] [Abstract][Full Text] [Related]
10. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression.
Siavoshian S; Segain JP; Kornprobst M; Bonnet C; Cherbut C; Galmiche JP; Blottière HM
Gut; 2000 Apr; 46(4):507-14. PubMed ID: 10716680
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells.
Mahmud N; Petro B; Baluchamy S; Li X; Taioli S; Lavelle D; Quigley JG; Suphangul M; Araki H
Biol Blood Marrow Transplant; 2014 Apr; 20(4):480-9. PubMed ID: 24374212
[TBL] [Abstract][Full Text] [Related]
12. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
Sekhavat A; Sun JM; Davie JR
Biochem Cell Biol; 2007 Dec; 85(6):751-8. PubMed ID: 18059533
[TBL] [Abstract][Full Text] [Related]
13. Regulation of RANKL promoter activity is associated with histone remodeling in murine bone stromal cells.
Fan X; Roy EM; Murphy TC; Nanes MS; Kim S; Pike JW; Rubin J
J Cell Biochem; 2004 Nov; 93(4):807-18. PubMed ID: 15389882
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothelial cells involves histone acetylation.
Arts J; Lansink M; Grimbergen J; Toet KH; Kooistra T
Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):171-6. PubMed ID: 7646441
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal.
Young JC; Wu S; Hansteen G; Du C; Sambucetti L; Remiszewski S; O'Farrell AM; Hill B; Lavau C; Murray LJ
Cytotherapy; 2004; 6(4):328-36. PubMed ID: 16146885
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator.
Pulukuri SM; Gorantla B; Rao JS
J Biol Chem; 2007 Dec; 282(49):35594-603. PubMed ID: 17923479
[TBL] [Abstract][Full Text] [Related]
17. Histone acetylation influences thyroid hormone and retinoic acid-mediated gene expression.
Garcia-Villalba P; Jimenez-Lara AM; Castillo AI; Aranda A
DNA Cell Biol; 1997 Apr; 16(4):421-31. PubMed ID: 9150429
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors.
Ishihara K; Takahashi A; Kaneko M; Sugeno H; Hirasawa N; Hong J; Zee O; Ohuchi K
Life Sci; 2007 Mar; 80(13):1213-20. PubMed ID: 17258775
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
Law AY; Lai KP; Lui WC; Wan HT; Wong CK
Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
[TBL] [Abstract][Full Text] [Related]
20. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA
Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
